Diabetes

Educational resources

Leeds supplement_digital_index image

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Takeda webinar promotion  index image

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd.

Takeda logo

Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network

Commissioned by Takeda UK Ltd

This advertorial has been commissioned and developed by Takeda UK Ltd.

Trajenta animation updated index image

Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

20200311 DPP-4 inhibitor GinP supplement v10 digital version draft

Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities

Commissioned by Boehringer Ingelheim Limited

This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.